Abstract
Effect of the vasopeptidase inhibitor, omapatrilat, on bradykinin metabolism in a model of left ventricular hypertrophy induced by myocardial infarction
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have